Neurowave Medical Technologies is Founded by the Acquisition of all Assests Pertaining to Neuromodulation Technology Platform from Abbott Laboratories
FDA clearance approved in four major clinical markets:
• Pregnancy Induced Nausea and Vomiting (NVP)
• Chemotherapy Induced Nausea and Vomiting (CINV)
• As an adjunct to anti-emetics in Post Operative Nausea (PON)
• Motion Sickness Induced Nausea and Vomiting (MSNV)

PrimaBella is Launched in the United States
Indicated for the Treatment of Pregnancy Induced Nausea and Vomiting

Reletex is Launched in the United States
Indicated as an adjunct to anti-emetics for the Treatment of Post Operative Nausea

Nometex is Launched in the United States
Indicated for the Treatment of Chemotherapy Induced Nausea and Vomiting